| ²é¿´: 846 | »Ø¸´: 14 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
nyj1116½ð³æ (СÓÐÃûÆø)
δÀ´¾«Ó¢
|
[½»Á÷]
»¯Ñ§Ò©ÎïµÄÖÆ¼ÁµÄÒ»°ã²½Ö裿£¿£¿£¿
|
||
| Ò»ÖÖ»¯Ñ§Ò©ÎïÒª×öËüµÄµÄÆÕͨ¼ÁÐÍ£¬ÈçÆ¬¼Á£¬»º¿ØÊÍÖÆ¼Á·ÖÉ¢¼ÁµÈ£¬Ò»°ã´ÓÄÄ¿ªÊ¼£¬ÒªÔõô×ö£¿Ò»°ãÁ÷³ÌÊÇʲô£¿£¿ |
» ²ÂÄãϲ»¶
284Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´
²ÄÁÏ¿ÆÑ§Ó빤³Ìµ÷¼Á
ÒѾÓÐ5È˻ظ´
346Çóµ÷¼Á Ò»Ö¾Ô¸070303Óлú»¯Ñ§
ÒѾÓÐ4È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
Ò»Ö¾Ô¸ÄϺ½ 335·Ö | 0856²ÄÁÏ»¯¹¤ | GPA 4.07 | ÓпÆÑоÀú
ÒѾÓÐ7È˻ظ´
322Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
¿¼Ñе÷¼Á
ÒѾÓÐ5È˻ظ´
307Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
292Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
±¾¿Æ211ÉúÎïҽѧ¹¤³Ì085409Çóµ÷¼Á339·Ö
ÒѾÓÐ3È˻ظ´

mspharm
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1165.1
- Ìû×Ó: 333
- ÔÚÏß: 48.4Сʱ
- ³æºÅ: 222783
- ×¢²á: 2006-03-21
- ÐÔ±ð: GG
- רҵ: ÉúÎï²ÄÁÏ
4Â¥2009-06-09 23:07:14
anonymous8973
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3566.4
- É¢½ð: 310
- ºì»¨: 2
- Ìû×Ó: 655
- ÔÚÏß: 175.4Сʱ
- ³æºÅ: 585238
- ×¢²á: 2008-08-08
- רҵ: Ò©Îï´úлÓëÒ©ÎﶯÁ¦Ñ§
¡ï ¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
karl2100(½ð±Ò+1,VIP+0):¶àлָ½Ì£¡ 6-11 23:34
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
karl2100(½ð±Ò+1,VIP+0):¶àлָ½Ì£¡ 6-11 23:34
| ÏÖ²éÖйúÒ©µä»òÊÞÒ©µä£¬ÒÔ¼°ÖÊÁ¿±ê×¼£¬ÔÙ²é¸÷¹úÒ©µä£¬Á˽âËüµÄÐÔ×´£¬Ä¿Ç°Êг¡ÉÏÓÐʲô¼ÁÐÍ¡£Ö®ºó¿´¿´ÎÄÏ×É϶ÔËüµÄÆÀ¼ÛµÈ£¬ÔÙ¿´¿´Äܲ»ÄÜËѵ½¹úÍâµÄ´¦·½¡£µÈÄãÓÐÁË×ÜÌå°ÑÎÕ£¬°´ÕÕÄã¶Ô¸Ã¼ÁÐ͵ÄÀí½â£¬È«Ã濼ÂÇÖÆ¼Á³ÉÐ͵ÄÓ°ÏìÒòËØ£¬½øÐе¥ÒòËØ¿¼²ì£¬ÓбØÒªÔÙ½øÐÐÕý½»Éè¼Æ»ò¾ùÔÈÉè¼Æ¡£ÔÚ×îºóÆÀ¼Ûһϡ£ |
2Â¥2009-06-09 08:22:09
nyj1116
½ð³æ (СÓÐÃûÆø)
δÀ´¾«Ó¢
- Ó¦Öú: 4 (Ó×¶ùÔ°)
- ½ð±Ò: 885.5
- É¢½ð: 75
- ºì»¨: 1
- Ìû×Ó: 293
- ÔÚÏß: 60.1Сʱ
- ³æºÅ: 728129
- ×¢²á: 2009-03-21
- רҵ: Ò©Îï·ÖÎö

3Â¥2009-06-09 21:45:02
anonymous8973
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3566.4
- É¢½ð: 310
- ºì»¨: 2
- Ìû×Ó: 655
- ÔÚÏß: 175.4Сʱ
- ³æºÅ: 585238
- ×¢²á: 2008-08-08
- רҵ: Ò©Îï´úлÓëÒ©ÎﶯÁ¦Ñ§
¡ï
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
Сľ³æ(½ð±Ò+0.5):¸ø¸öºì°ü£¬Ð»Ð»»ØÌû½»Á÷
| ºÇºÇ£¬Â¥ÉÏ˵µÄÊÇ¡£¡¶Pharmaceutical Preformulation and Formulation¡·ÊéÉϺÜÇ¿µ÷preformulation£¬ºÜ¶à¿ÆÑй¤×÷Õß¶ÔÕâ·½ÃæÖØÊӱȽÏС¡£ |
5Â¥2009-06-10 15:35:52














»Ø¸´´ËÂ¥